/https://specials-images.forbesimg.com/imageserve/5bb7ad404bbe6f67d2e8aa11/0x0.jpg)
EMA begins review of GBT’s sickle cell treatment Oxbryta
The European Medicines Company (EMA) has actually accepted a marketing authorisation application for Worldwide Blood Restorative's (GBT) Oxbryta (voxelotor). ...
Tag: GBTs
Get the latest news and follow the coverage of Tech updates, science, breakthrough research news and more from the top trusted sources.